Skip to main content
Caplight Logo









T-Lab

T-Lab

Private
TurkeyHealthcare & Life Scienceshttps://tlab.com.au

Last Round

Seed

Sep 23, 2021

Total Funding Raised

$1.6M

Company Overview

T-Lab operates in Healthcare & Life Sciences and is based in Turkey. Its latest recorded funding round was a Seed round in September 2021.

T-Lab is a medical technology company that specializes in the development and manufacturing of regenerative medicine products, including platelet-rich plasma (PRP) kits and stem cell isolation devices.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

T-Lab Comparables

Compare T-Lab with similar companies based on industry and business-model similarity.

T-Lab comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alocuro
91%
Celling Biosciences
84%
Royal Biologics
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

T-Lab Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 23, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

T-Lab Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2021

    $1.6M round led by East Ventures

Book a demo to see all signals

For institutional investors. Book with your work email.

T-Lab Filings

Explore SEC and related filing metadata, where available.

T-Lab filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about T-Lab's valuation, stock price, and market status.

Is T-Lab a public or private company?

T-Lab is a private company.

What is the current stock price of T-Lab?

T-Lab is a private company, so its shares have no public market price. Caplight tracks T-Lab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is T-Lab worth (valuation)?

Valuation information for T-Lab is not publicly available.

Can I buy T-Lab stock?

T-Lab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was T-Lab's last funding round?

T-Lab's most recent funding round was Seed on September 23, 2021.

Who are the main investors in T-Lab?

Key investors in T-Lab include East Ventures.

Will T-Lab IPO soon?

No public IPO plans have been announced for T-Lab.

How can I track T-Lab secondary market activity?

Caplight tracks bids, offers, and trades in T-Lab's shares on secondary markets.

Firmographic Details

HeadquartersTurkey
Year Founded2012
Last FundingSep 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?